Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
41
Frequently Asked Questions
What is Market Cap of Cue Biopharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cue Biopharma Inc market cap is $60.32M.
What is the 52-week high for Cue Biopharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cue Biopharma Inc 52 week high is $1.99 as of September 06, 2025.
What is the 52-week low for Cue Biopharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cue Biopharma Inc 52 week low is $0.45 as of September 06, 2025.
What is Cue Biopharma Inc stock price today?
Cue Biopharma Inc stock price today is $0.78.
What was Cue Biopharma Inc stock price yesterday?
Cue Biopharma Inc stock price yesterday was $0.785.
What is the PE ratio of Cue Biopharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cue Biopharma Inc’s P/E ratio is -1.42.
What is the Price-to-Book ratio of Cue Biopharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cue Biopharma Inc P/B ratio is 3.3047.
What is the 50-day moving average of Cue Biopharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cue Biopharma Inc 50-day moving average is $0.798.
